Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK0773 in healthy older men.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Subject is in good general health

• Subject agrees to avoid excess alcohol and strenuous physical activity during the study

• Subject who is sexually active with partners of reproductive potential agrees to use two forms of appropriate contraception during the study

Exclusion Criteria:

• Subject has significant drug allergies

• Subject has donated blood within the last 8 weeks or has taken an investigational drug in another clinical trial within the last 4 weeks

• Subject is a regular user or past abuser of any illicit drug (including alcohol)

• Subject drinks excessive amounts of caffeinated beverages

• Subject has a history of cancer

• Subject has a history of prostate or testicular surgery